InvestorsHub Logo
Followers 21
Posts 1996
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Thursday, 01/20/2022 12:55:01 PM

Thursday, January 20, 2022 12:55:01 PM

Post# of 4160
"I am honored to return as the Interim CEO for the Company, as the Company
realigns its executive management team to focus on the Company’s primary
objective of commercialization of its ACT technology, which, if successful, will ultimately deliver shareholder value."

Dr Arkady Mandel
Interim CEO & CSO, Theralase®

JMO, maybe, maybe not.